Arcellx (ACLX) Stock Forecast & Price Target

→ [Urgent] Protect your money before November (From Weiss Ratings) (Ad)

$53.81

+0.06 (+0.11%)

(As of 06/18/2024 ET)

Arcellx - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 14 Analyst Ratings

Consensus Price Target

$78.00
44.95% Upside

High Forecast	$87.00
Average Forecast	$78.00
Low Forecast	$52.00

Type	Current Forecast 6/20/23 to 6/19/24	1 Month Ago 5/21/23 to 5/20/24	3 Months Ago 3/22/23 to 3/21/24	1 Year Ago 6/20/22 to 6/20/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	12 Buy rating(s)	13 Buy rating(s)	10 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$78.00	$78.73	$69.14	$51.58
Forecasted Upside	44.95% Upside	33.94% Upside	17.10% Upside	50.41% Upside

Get Arcellx Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ACLX and its competitors with MarketBeat's FREE daily newsletter.

Ad Paradigm Press

Musk’s new company could top a trillion?

The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.

Click here to see the details because there’s not much time to prepare.

ACLX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ACLX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Arcellx Stock vs. The Competition

Type	Arcellx	Medical Companies	S&P 500
Consensus Rating Score	3.07	2.70	2.50
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	44.95% Upside	1,068.18% Upside	11.31% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
6/18/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$87.00 ➝ $87.00	+61.62%
5/31/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Amin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$70.00	+34.00%
5/15/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$82.00 ➝ $83.00	+63.97%
5/14/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$85.00	+70.79%
5/13/2024	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$82.00 ➝ $80.00	+64.20%
5/7/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$81.00	+53.79%
Get the Latest News and Ratings for ACLX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arcellx and its competitors with MarketBeat's FREE daily newsletter.
4/4/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform	$82.00	+29.75%
3/7/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$81.00	+11.03%
2/29/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$66.00 ➝ $85.00	+28.55%
2/29/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$62.00 ➝ $73.00	+8.44%
2/29/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$63.00 ➝ $77.00	+14.38%
10/30/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform
10/17/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$52.00	+52.67%
10/12/2023	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Graybosch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
5/10/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$39.00 ➝ $50.00	+10.52%
4/24/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$45.00 ➝ $58.00	+45.22%
3/30/2023	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$35.00 ➝ $39.00	+27.74%
3/30/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$35.00 ➝ $39.00	+25.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:01 AM ET.

ACLX Forecast - Frequently Asked Questions

What is Arcellx's stock forecast and purchase recommendation?: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Arcellx is $78.00, with a high forecast of $87.00 and a low forecast of $52.00. The consensus rating for Arcellx stock is Buy based on the current 13 buy ratings and 1 strong buy rating for ACLX. Learn more on ACLX's analyst rating history.
Do Wall Street analysts like Arcellx more than its competitors?: Analysts like Arcellx more than other "medical" companies. The consensus rating for Arcellx is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ACLX compares to other companies.
Is Arcellx being upgraded by Wall Street analysts?: Over the previous 90 days, Arcellx's stock had 1 upgrade by analysts.

Does Arcellx's stock price have much upside?: According to analysts, Arcellx's stock has a predicted upside of 37.17% based on their 12-month stock forecasts.
What analysts cover Arcellx?: Arcellx has been rated by research analysts at Evercore ISI, HC Wainwright, Needham & Company LLC, Piper Sandler, Scotiabank, Stifel Nicolaus, and Truist Financial in the past 90 days.